Health Care System Factors for Tuberculosis (TB) Cases
Health Care System Factors
It is very important that patients with active tuberculosis (TB) disease adhere to their treatment regimen. Treatment adherence is not only important for effective therapy in patients, but also to prevent an increase in cases of drug-resistant ''Mycobacterium tuberculosis''. From 2015 to 2019, drug susceptibility testing was completed on 100% (98 of 98) of the TB cases confirmed by laboratory culture. During this period, 15% of culture isolates had resistance to one or more anti-TB medications relative to the total number of laboratory culture confirmed TB cases. These statistics highlight the need for continued drug sensitivity testing for all TB culture isolates, and the need for directly observed therapy (DOT) for all TB patients to ensure that they take all their medications.
Tuberculosis Control Program, Bureau of Epidemiology, Division of Disease Control and Prevention, Utah Department of Health, Salt Lake City, UT 84114-2104, Telephone: 801-538-6191, Fax: 801-538-9913, Website: http://www.health.utah.gov/epi/diseases/TB, Contact: Hayder Allkhenfr, Program Manager; Rachel Ashby, Epidemiologist, email: hallkhenfr@utah.gov, rashby@utah.gov
The information provided above is from the Department of Health's Center for
Health Data IBIS-PH web site (http://ibis.health.state.gov). The information published
on this website may be reproduced without permission. Please use the following citation:
"
Retrieved
Fri, 14 May 2021 8:09:25
from Department of Health, Center for Health Data, Indicator-Based Information
System for Public Health Web site: http://ibis.health.state.gov
".
